Clinical Trial Update: 5 Years Long Term Results After Standalone CyPass-Implantation

View source ↗

Summary

Five-year long-term results update from a standalone CyPass implantation trial for glaucoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• CyPass (hydroxyethyl methacrylate polymer microstent (CyPass))

Snippet

Sponsor: Dietrich-Bonhoeffer-Klinikum | Conditions: Glaucoma | Status: COMPLETED | Results posted: 2022-07-14